FDA says product mislabeled, misleading

Nov 20, 2007

U.S. regulators seized about $2 million of potentially harmful eye products that contain a drug ingredient officials said could lead to decreased vision.

At the request of the U.S. Food and Drug Administration, federal marshals seized 12,682 tubes of Age Intervention Eyelash, a product that may, in some users, lead to decreased vision, the FDA said in a news release. Authorities said the seized tubes could have generated about $2 million in sales.

The FDA said it considered Age Intervention Eyelash an unapproved and improperly branded drug because Jan Marini Skin Research promoted the product to increase eyelash growth. The regulator said it also considered the product to be an adulterated cosmetic because it contains bimatoprost, an active ingredient in an FDA-approved drug used to treat elevated pressure inside the eye.

The FDA said patients taking the prescription drug may have an increased risk of optic nerve damage if they use Age Intervention Eyelash. Because it contains bimatoprost, Age Intervention Eyelash also may cause adverse effects in some people, including macular edema and uveitis.

The FDA recommended that consumers, dermatologists and estheticians discontinue using Age Intervention Eyelash and discard the product.

Copyright 2007 by United Press International

Explore further: Invasive procedures down with noninvasive prenatal testing

add to favorites email to friend print save as pdf

Related Stories

Poll: Americans skeptical of commercial drones

22 minutes ago

Americans are skeptical that the benefits of the heralded drone revolution will outweigh the risks to privacy and safety, although a majority approve of using small, unmanned aircraft for dangerous jobs or ...

Warming leads to more run-ins with polar bears

2 minutes ago

Word spread quickly: a polar bear, then two, were spotted near this remote Inuit village on the shores of Hudson Bay, about 1,800 kilometers (1,120 miles) north of Montreal.

Japanese scientist resigns over stem cell scandal

40 minutes ago

A researcher embroiled in a fabrication scandal that has rocked Japan's scientific establishment said Friday she would resign after failing to reproduce results of what was once billed as a ground-breaking study on ...

Recommended for you

New approach to particle therapy dosimetry

16 hours ago

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.